510(k) device
Atrial Fibrillation History Feature
Apple, Inc. · Photoplethysmograph Analysis Software For Over-The-Counter Use (QDB, Class II) · First FDA decision Jun 3, 2022, newest Jun 3, 2022Atrial fibrillation
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
4
Naming "Fibrillation History Feature"
MAUDE reports
0
Brand "Fibrillation History Feature", since 2015
PubMed studies
0
Mentioning "Fibrillation History Feature"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Atrial Fibrillation History Feature
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
K213971 · Decided Jun 3, 2022 · 165 days after receipt
Device type: Photoplethysmograph Analysis Software For Over-The-Counter Use (QDB) · Cardiology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Fibrillation History Feature", any status and sponsor, newest update first.
The Cleveland ClinicAcademic, hospital or other
NCT07122947 · 75 participants (planned) · Start Jun 2, 2025 · Primary completion Dec 31, 2027
Device: Apple Watch: AFib History; Zio Patch · For: Atrial Fibrillation
Sites: St Louis, Missouri; Cleveland, Ohio
University Hospital of FerraraAcademic, hospital or other
NCT06324682 · 8,400 participants (planned) · Start Jan 1, 2023 · Primary completion Dec 31, 2033
Device: Cardiac pacing - Conventional RV pacing; Cardiac pacing - Conduction System Pacing and 3 more · For: Arrhythmias, Cardiac; Atrioventricular Block; Reduced Systolic Function and 22 more
Sites: Ferrara, Italy; Arezzo, Italy; Bologna, Italy · 31 sites in all
- Clinical Validation of the Electrocardiogram MeasurementStatus unknown
Taipei Medical University HospitalAcademic, hospital or other
NCT05830578 · 602 participants (planned) · Start Dec 1, 2023 · Primary completion Jun 30, 2024
Device: ASUS Blood Pressure Monitor/Oximeter/ECG Monitor · For: Atrial Fibrillation
1 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Fibrillation History Feature", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code QDB
1 reports: 1 malfunction, 0 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Fibrillation History Feature"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code QDB.
- Irregular Rhythm Notification Feature (IRNF)Apple, Inc. · De Novo 2023
- Fitbit Irregular Rhythm NotificationsFitbit, Inc. · 510(k) 2022
- IRNF AppApple, Inc. · 510(k) 2021
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.